198 assets in Major Depressive Disorder

Therapeutic assets addressing Major Depressive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
gh001 Major Depressive Disorder	GH Research Ireland Limited	P2	CCC (55)
Mitizodone Phosphate Tablets Major Depressive Disorder	Sunshine Lake Pharma Co., Ltd.	P2/3	CCC (55)
Nrx-101 Major Depressive Disorder	NeuroRx, Inc.	P2/3	CCC (55)
Onfasprodil Major Depressive Disorder	Novartis Pharmaceuticals	P2	CCC (55)
Progesterone Major Depressive Disorder	University of North Carolina, Chapel Hill	P4	CCC (55)
sp-624 Major Depressive Disorder	Sirtsei Pharmaceuticals, Inc.	P2	CCC (55)
Alto-100 Po Major Depressive Disorder	Alto Neuroscience	P2	CCC (54)
Alto-300 Major Depressive Disorder	Alto Neuroscience	P2	CCC (54)
Human Faecal Matter Major Depressive Disorder	Valerie Taylor	P2/3	CCC (54)
Opakalim Major Depressive Disorder	Biohaven Therapeutics Ltd.	P2	CCC (54)
Phenelzine Major Depressive Disorder	University of California, San Francisco	P4	CCC (54)
Solriamfetol Major Depressive Disorder	Axsome Therapeutics, Inc.	P3	CCC (54)
Acp-211 Major Depressive Disorder	ACADIA Pharmaceuticals Inc.	P2	CCC (53)
Alto-207 Major Depressive Disorder	Alto Neuroscience	P2	CCC (53)
Dasatinib Major Depressive Disorder	Washington University School of Medicine	P2	CCC (53)
dt-101 Major Depressive Disorder	Draig Therapeutics Ltd	P2	CCC (53)
Flavone, 3,3',4',5,7-Pentahydroxy- Major Depressive Disorder	Washington University School of Medicine	P2	CCC (53)
High Dose Prt042 Nasal Spray Major Depressive Disorder	Sichuan Purity Pharmaceutical Technology Co., Ltd.	P2	CCC (53)
Infliximab Major Depressive Disorder	Massachusetts General Hospital	P2	CCC (53)
Jnj-89495120 Major Depressive Disorder	Janssen Research & Development, LLC	P2	CCC (53)
Lactobacillus Crispatus Major Depressive Disorder	First Affiliated Hospital of Chongqing Medical University	P2	CCC (53)
Lemborexant Major Depressive Disorder	Unity Health Toronto	P2	CCC (53)
L-Leucine Major Depressive Disorder	Emory University	P2	CCC (53)
Low Dose Prt042 Nasal Spray Major Depressive Disorder	Sichuan Purity Pharmaceutical Technology Co., Ltd.	P2	CCC (53)
LYSINE Major Depressive Disorder	Emory University	P2	CCC (53)
Magnesium Metallicum Major Depressive Disorder	University of Child Health Sciences and Children's Hospital, Lahore	P2	CCC (53)
Medi-Tbs Major Depressive Disorder	University of California, San Diego	P2	CCC (53)
(-)-Osu 6162 Major Depressive Disorder	Göteborg University	P2	CCC (53)
Selenium Major Depressive Disorder	First Affiliated Hospital of Chongqing Medical University	P2	CCC (53)
Spn-821 Major Depressive Disorder	Supernus Pharmaceuticals, Inc.	P2	CCC (53)
Spt-300 Major Depressive Disorder	Seaport Therapeutics	P2	CCC (53)
Vls-01-203 Bu Major Depressive Disorder	atai Therapeutics, Inc.	P2	CCC (53)
Amisulpride Major Depressive Disorder	Simone Grimm	P1	CCC (52)
Aspirin Major Depressive Disorder	Assistance Publique - Hôpitaux de Paris	P2	CCC (52)
Clozapine Major Depressive Disorder	Dr. Inge Winter	P3	CCC (52)
dt120 Major Depressive Disorder	Definium Therapeutics US, Inc.	P3	CCC (52)
hs-10353 Major Depressive Disorder	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P2	CCC (52)
Modafinil Major Depressive Disorder	University of Minnesota	P3	CCC (52)
Ono-1110 Major Depressive Disorder	Ono Pharmaceutical Co., Ltd.	P2	CCC (52)
Rosuvastatin Major Depressive Disorder	Ain Shams University	P3	CCC (52)
Valproate Acid Major Depressive Disorder	Dr. Inge Winter	P3	CCC (52)
Alto-203 Major Depressive Disorder	Alto Neuroscience	P2	CCC (51)
Alto-300 Po Major Depressive Disorder	Alto Neuroscience	P2	CCC (51)
Centanafadine, (+)- Major Depressive Disorder	Otsuka Pharmaceutical Development & Commercialization, Inc.	P2	CCC (51)
Emestedastat Major Depressive Disorder	Actinogen Medical	P2	CCC (51)
gm-1020 Major Depressive Disorder	Gilgamesh Pharmaceuticals	P2	CCC (51)
Ixekizumab Major Depressive Disorder	Icahn School of Medicine at Mount Sinai	P2	CCC (51)
Nbi-1065846 Major Depressive Disorder	Neurocrine Biosciences	P2	CCC (51)
Nbi-1070770 Major Depressive Disorder	Neurocrine Biosciences	P2	CCC (51)
Ulotaront Major Depressive Disorder	Otsuka Pharmaceutical Development & Commercialization, Inc.	P2	CCC (51)

Showing 101 to 150 of 198 assets

PreviousPage 3 of 4Next